Charles Lin Email & Phone Number

Boston, MA, US

Greater Boston

Business Development and Licensing

Greater Boston

• Identified and evaluated external business opportunities for in/out-licensing, co-development, structured transactions and investment.
• Developed persuasive business cases for prioritized external opportunities, using robust analyses, key assumptions and risks, and internal and external input to provide clear recommendations to the management team.
• Led cross-functional execution from proposal to deal closure and alliance management, working closely with R&D, CMC, Clinical, Regulatory, Operations, Finance and Legal teams, and provided regular executive reporting.
• Represented cooperation at industry, investor, and partnering conferences, and foster strong relationships with a diverse range of pharmaceutical and biotechnology industry participants.

Greater Boston

• Managed existing life science, biomedical and biotech project pipelines while developing new business opportunities, leading in-licensing, distribution, and partnership projects from initial to deal negotiation, and.
• Identified 50+ transformational technologies while shaping emerging science to address unmet needs ranging from ideas, IPs, research articles, conferences, presses, and events.
• Participated in global investment and M&A by deal sourcing, underwriting investment opportunities, providing scientific insights, cross-functional Due Diligence, and generating Due Diligence reports across target.
• Facilitated in investments for internal and external (VC/PE) entities across 20+ new tech ventures spanning early- to late-stage privately held companies in North America, Europe, Asia, and Australia.

Greater Boston

• Advised 2 FDA regulatory applications and 7 novel product innovations and strategy design initiatives.
• Managed 40+ life science/biomedical projects.
• Established collaborative research and selected valuable patents from joint research for evaluation and incubation.

• Designed, proposed, and executed research projects to investigate host antiviral immunity and pathogenic mechanisms of viral infection at in vivo and in vitro levels.
• Delivered 4 significant presentations at well-known professional conferences, focused on the molecular function of host genes that influences viral pathogenesis and disease outcomes.
• Led 3 research proposals and School of Medicine’s annual research program review panel, completed fundraising for the NIH and University of Connecticut.
• Served as reviewer over 2 years in the School of Medicine’s Annual Research Program review panel.

• Led 2 NIH and 1 NSF grants to investigate biomolecular interaction mechanisms and diagnostic designs.
• Benchmarked intracellular fluorescence resonance energy transfer using in-house protein-protein interaction library.
• Mentored and trained 14 laboratory members across different education levels.
• Selected as Howard Hughes Medical Institute (HHMI) Scientific Teaching Fellow, awarded to those with a demonstrated commitment to mentoring biomedical research.

• Introduced innovative new methods for characterizing protein-protein interactions.
• Demonstrated novel PPI applicability in discovering functions of yet unknown proteins in the human and animal genome.

• Reported on molecular epidemiology of 8 emerging, re-emerging, and zoonotic viruses in China that are of public health importance.
• Characterized the structure, function, and molecular mechanisms of 7 structural and nonstructural proteins in PRRS virus genome.
• Developed 3 novel genetically engineered vaccine candidates against PRRSV or PCV type 2, which causes substantial financial and economic loss globally.
• Evaluated the efficiency of a novel adjuvant for commercialized vaccines against influenza virus (won Excellent Thesis Award, top 3%).

Digital Transformation

Iacuc / Ccm

Phd, Dvm, Infectious Disease, Molecular Virology And Epidemiology